Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
CASE REPORTS
Wandering Pneumonia Caused by Dabigatran
Masakazu Kono, Kousuke Hirota, Ayako Yokoe, Chie Koumura, Toshihiko Sakai, Hirokazu Tojima
Author information
JOURNAL OPEN ACCESS

2014 Volume 53 Issue 16 Pages 1825-1827

Details
Abstract
We herein describe the case of a 74-year-old man who experienced pulmonary consolidation and chest pain following administration of dabigatran, a novel oral anticoagulant. The consolidation settled spontaneously in another lung area, a condition sometimes referred to as "wandering pneumonia." Although we did not find specific pathological evidence of interstitial lung disease on transbronchial lung biopsy, a lung opacity spontaneously disappeared following discontinuance of dabigatran, and there was no recurrence. There are no other reports of dabigatran-induced lung injury, except alveolar hemorrhage and eosinophilic pneumonia. We should consider that any novel drug could cause various types of pulmonary injuries.
Content from these authors
© 2014 by The Japanese Society of Internal Medicine
Previous article Next article
feedback
Top